140 related articles for article (PubMed ID: 6217929)
1. Impaired degradation of chondroitin sulfate in GM2-gangliosidosis.
Yutaka T; Kato T; Okada S; Yabuuci H
Clin Genet; 1982 Oct; 22(4):165-71. PubMed ID: 6217929
[TBL] [Abstract][Full Text] [Related]
2. Degradation of keratan sulfate by beta-N-acetylhexosaminidases in GM2-gangliosidosis.
Yutaka T; Okada S; Kato T; Yabuuhi H
Clin Genet; 1982 Mar; 21(3):196-202. PubMed ID: 6212169
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Tay-Sachs disease by estimation of beta-N-acetylhexosaminidase activity using a radiolabeled hyaluronic acid-derived trisaccharide substrate.
Yutaka T; Kato T; Midorikawa M; Doke M; Okada S; Yabuuchi H
Clin Chim Acta; 1984 Feb; 137(2):159-68. PubMed ID: 6231138
[TBL] [Abstract][Full Text] [Related]
4. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
Harzer K
Clin Chim Acta; 1983 Nov; 135(1):89-93. PubMed ID: 6228344
[No Abstract] [Full Text] [Related]
5. Chromatofocusing coupled with automated assay for beta-hexosaminidase isoenzymes in GM2 gangliosidosis.
Orlacchio A; Maffei C; Emiliani C; Coppa GV; Felici L
Experientia; 1985 Apr; 41(4):525-7. PubMed ID: 3157597
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of the (1 goes to 3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl linkage present in keratan sulfate. The A and B isoenzymes of human liver hexosaminidase (EC 3.2.1.30).
Toma S; Coppa G; Donnelly PV; Ricci R; Di Ferrante N; Srivastava SK
Carbohydr Res; 1981 Oct; 96(2):271-90. PubMed ID: 6458358
[TBL] [Abstract][Full Text] [Related]
7. Liberation of N-acetylglucosamine-6-sulfate by human beta-N-acetylhexosaminidase A.
Kresse H; Fuchs W; Glössl J; Holtfrerich D; Gilberg W
J Biol Chem; 1981 Dec; 256(24):12926-32. PubMed ID: 6458607
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
Bayleran J; Hechtman P; Saray W
Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
[TBL] [Abstract][Full Text] [Related]
9. Production of recombinant beta-hexosaminidase A, a potential enzyme for replacement therapy for Tay-Sachs and Sandhoff diseases, in the methylotrophic yeast Ogataea minuta.
Akeboshi H; Chiba Y; Kasahara Y; Takashiba M; Takaoka Y; Ohsawa M; Tajima Y; Kawashima I; Tsuji D; Itoh K; Sakuraba H; Jigami Y
Appl Environ Microbiol; 2007 Aug; 73(15):4805-12. PubMed ID: 17557860
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
Poulos A; Holding J; Carey WF
Clin Chim Acta; 1982 Apr; 120(3):331-40. PubMed ID: 6210469
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
13. [Biosynthesis and biodegradation of GM2 ganglioside].
Hirabayashi Y; Kasakura H; Matsumoto M
Tanpakushitsu Kakusan Koso; 1984 Sep; 29(9):708-22. PubMed ID: 6240072
[No Abstract] [Full Text] [Related]
14. GM2-gangliosidosis. Clinical and biochemical aspects of four cases.
Praamstra P; Wevers RA; Gabreëls FJ; Rotteveel JJ; Renier WO; Sengers RC; Lamers KJ
Clin Neurol Neurosurg; 1990; 92(2):143-8. PubMed ID: 2163796
[TBL] [Abstract][Full Text] [Related]
15. Classification of disorders of GM2 ganglioside hydrolysis using 3H-GM2 as substrate.
Novak A; Callahan JW; Lowden JA
Biochim Biophys Acta; 1994 Mar; 1199(2):215-23. PubMed ID: 8123671
[TBL] [Abstract][Full Text] [Related]
16. Degradation of keratan sulphate by beta-N-acetylhexosaminidases A and B.
Ludolph T; Paschke E; Glössl J; Kresse H
Biochem J; 1981 Mar; 193(3):811-8. PubMed ID: 6458277
[TBL] [Abstract][Full Text] [Related]
17. The biochemical basis of gangliosidoses.
Sandhoff K; Conzelmann E
Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
[No Abstract] [Full Text] [Related]
18. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
Christopher R; Rangaswamy GR; Shetty KT
Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
[TBL] [Abstract][Full Text] [Related]
19. Lyso-GM2 ganglioside: a possible biomarker of Tay-Sachs disease and Sandhoff disease.
Kodama T; Togawa T; Tsukimura T; Kawashima I; Matsuoka K; Kitakaze K; Tsuji D; Itoh K; Ishida Y; Suzuki M; Suzuki T; Sakuraba H
PLoS One; 2011; 6(12):e29074. PubMed ID: 22205997
[TBL] [Abstract][Full Text] [Related]
20. beta-hexosaminidase in cultured normal and mutant human fibroblasts: an immunohistochemical and biochemical investigation.
Elsafi ME; Elbashir MI; Hultberg B; Isaksson A; Hägerstrand I; Stenram U
Scand J Clin Lab Invest; 1991 Dec; 51(8):711-4. PubMed ID: 1839650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
